Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience

Cécile Chung , Sébastien Bommart (1, 2) , Sylvain Marchand-Adam , Mathieu Lederlin , Ludovic Fournel , Marie-Christine Charpentier , Lionel Groussin , Marie Wislez , Marie-Pierre Revel , Guillaume Chassagnon

1 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]

Diffuse pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare pre-invasive disease whose pathophysiology remains unclear. We aimed to assess long-term evolution in imaging of DIPNECH, in order to propose follow-up recommendations. Patients with histologically confirmed DIPNECH from four centers, evaluated between 2001 and 2020, were enrolled if they had at least two available chest computed tomography (CT) exams performed at least 24 months apart. CT exams were analyzed for the presence and the evolution of DIPNECH-related CT findings. Twenty-seven patients, mostly of female gender (n = 25/27; 93%) were included. Longitudinal follow-up over a median 63-month duration (IQR: 31–80 months) demonstrated an increase in the size of lung nodules in 19 patients (19/27, 70%) and the occurrence of metastatic spread in three patients (3/27, 11%). The metastatic spread was limited to mediastinal lymph nodes in one patient, whereas the other two patients had both lymph node and distant metastases. The mean time interval between baseline CT scan and metastatic spread was 70 months (14, 74 and 123 months). Therefore, long-term annual imaging follow-up of DIPNECH might be appropriate to encompass the heterogeneous longitudinal behavior of this disease.

Domaines: Sciences du Vivant [q-bio]

Cécile Chung, Sébastien Bommart, Sylvain Marchand-Adam, Mathieu Lederlin, Ludovic Fournel, et al.. Long-Term Imaging Follow-Up in DIPNECH: Multicenter Experience. Journal of Clinical Medicine, 2021, 10 (13), pp.2950. ⟨10.3390/jcm10132950⟩. ⟨hal-03277611⟩